TP
MRNA icon

Theleme Partners’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$217M Buy
7,868,810
+626,420
+9% +$17.3M 13.2% 1
2025
Q1
$205M Sell
7,242,390
-64,471
-0.9% -$1.83M 16.14% 1
2024
Q4
$304M Buy
7,306,861
+80,000
+1% +$3.33M 20.36% 1
2024
Q3
$483M Hold
7,226,861
27.61% 1
2024
Q2
$858M Sell
7,226,861
-94,936
-1% -$11.3M 41.17% 1
2024
Q1
$780M Sell
7,321,797
-27,659
-0.4% -$2.95M 39.54% 1
2023
Q4
$731M Buy
7,349,456
+451,844
+7% +$44.9M 34.86% 1
2023
Q3
$712M Buy
6,897,612
+651,113
+10% +$67.3M 35.78% 1
2023
Q2
$759M Buy
6,246,499
+134,065
+2% +$16.3M 34.35% 1
2023
Q1
$939M Buy
6,112,434
+253,576
+4% +$38.9M 40.37% 1
2022
Q4
$1.05B Sell
5,858,858
-145,548
-2% -$26.1M 39.69% 1
2022
Q3
$710M Sell
6,004,406
-350,000
-6% -$41.4M 34.63% 1
2022
Q2
$908M Buy
6,354,406
+17,466
+0.3% +$2.5M 36.37% 1
2022
Q1
$1.09B Buy
6,336,940
+1,314,766
+26% +$226M 34.87% 1
2021
Q4
$1.28B Buy
5,022,174
+1,065,100
+27% +$271M 21.32% 1
2021
Q3
$1.52B Sell
3,957,074
-2,114,982
-35% -$814M 43.47% 1
2021
Q2
$1.43B Sell
6,072,056
-230,000
-4% -$54M 41.66% 1
2021
Q1
$825M Buy
6,302,056
+958,358
+18% +$125M 27.62% 1
2020
Q4
$558M Sell
5,343,698
-2,309,280
-30% -$241M 18.33% 2
2020
Q3
$541M Sell
7,652,978
-893,941
-10% -$63.2M 24.88% 1
2020
Q2
$549M Sell
8,546,919
-384,000
-4% -$24.7M 25.9% 1
2020
Q1
$267M Buy
8,930,919
+2,490,645
+39% +$74.6M 19.24% 2
2019
Q4
$126M Buy
6,440,274
+827,829
+15% +$16.2M 7.1% 5
2019
Q3
$89.4M Buy
5,612,445
+1,757,647
+46% +$28M 4.13% 8
2019
Q2
$56.4M Buy
3,854,798
+2,222,285
+136% +$32.5M 2.74% 9
2019
Q1
$33.2M Buy
1,632,513
+502,513
+44% +$10.2M 1.98% 8
2018
Q4
$17.3M Buy
+1,130,000
New +$17.3M 0.87% 9